A comprehensive study of insulin prices in nations similar to the U.S. finds that people in the U.S. pay significantly more for their insulin than people living in 32 other high income countries.Basing their conclusions on manufacturers’ prices for insulin, the new “analysis provides the best available evidence about how much more expensive insulin is in the U.S.
than in other nations around the world,” according to lead author Andrew Mulcahy, a senior policy researcher of the non-profit RAND Corporation.Funded by the U.S.
Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation, the research, titled “Comparing insulin prices in the United States to other countries: Results from a price index.